Global Aprepitant Market Growth 2022-2028
- LP 4798435
- 75 Pages
- January 2022
- Pharmaceuticals
The United States Aprepitant market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Aprepitant market, reaching US$ million by the year 2028. As for the Europe Aprepitant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Aprepitant players cover Merck & Co., Heron Therapeutics, Sandoz, and Glenmark Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Aprepitant market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection
Oral
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck & Co.
Heron Therapeutics
Sandoz
Glenmark Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aprepitant Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Aprepitant by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Aprepitant by Country/Region, 2017, 2022 & 2028
2.2 Aprepitant Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Aprepitant Sales by Type
2.3.1 Global Aprepitant Sales Market Share by Type (2017-2022)
2.3.2 Global Aprepitant Revenue and Market Share by Type (2017-2022)
2.3.3 Global Aprepitant Sale Price by Type (2017-2022)
2.4 Aprepitant Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Aprepitant Sales by Application
2.5.1 Global Aprepitant Sale Market Share by Application (2017-2022)
2.5.2 Global Aprepitant Revenue and Market Share by Application (2017-2022)
2.5.3 Global Aprepitant Sale Price by Application (2017-2022)
3 Global Aprepitant by Company
3.1 Global Aprepitant Breakdown Data by Company
3.1.1 Global Aprepitant Annual Sales by Company (2020-2022)
3.1.2 Global Aprepitant Sales Market Share by Company (2020-2022)
3.2 Global Aprepitant Annual Revenue by Company (2020-2022)
3.2.1 Global Aprepitant Revenue by Company (2020-2022)
3.2.2 Global Aprepitant Revenue Market Share by Company (2020-2022)
3.3 Global Aprepitant Sale Price by Company
3.4 Key Manufacturers Aprepitant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aprepitant Product Location Distribution
3.4.2 Players Aprepitant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Aprepitant by Geographic Region
4.1 World Historic Aprepitant Market Size by Geographic Region (2017-2022)
4.1.1 Global Aprepitant Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Aprepitant Annual Revenue by Geographic Region
4.2 World Historic Aprepitant Market Size by Country/Region (2017-2022)
4.2.1 Global Aprepitant Annual Sales by Country/Region (2017-2022)
4.2.2 Global Aprepitant Annual Revenue by Country/Region
4.3 Americas Aprepitant Sales Growth
4.4 APAC Aprepitant Sales Growth
4.5 Europe Aprepitant Sales Growth
4.6 Middle East & Africa Aprepitant Sales Growth
5 Americas
5.1 Americas Aprepitant Sales by Country
5.1.1 Americas Aprepitant Sales by Country (2017-2022)
5.1.2 Americas Aprepitant Revenue by Country (2017-2022)
5.2 Americas Aprepitant Sales by Type
5.3 Americas Aprepitant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aprepitant Sales by Region
6.1.1 APAC Aprepitant Sales by Region (2017-2022)
6.1.2 APAC Aprepitant Revenue by Region (2017-2022)
6.2 APAC Aprepitant Sales by Type
6.3 APAC Aprepitant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aprepitant by Country
7.1.1 Europe Aprepitant Sales by Country (2017-2022)
7.1.2 Europe Aprepitant Revenue by Country (2017-2022)
7.2 Europe Aprepitant Sales by Type
7.3 Europe Aprepitant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aprepitant by Country
8.1.1 Middle East & Africa Aprepitant Sales by Country (2017-2022)
8.1.2 Middle East & Africa Aprepitant Revenue by Country (2017-2022)
8.2 Middle East & Africa Aprepitant Sales by Type
8.3 Middle East & Africa Aprepitant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aprepitant
10.3 Manufacturing Process Analysis of Aprepitant
10.4 Industry Chain Structure of Aprepitant
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aprepitant Distributors
11.3 Aprepitant Customer
12 World Forecast Review for Aprepitant by Geographic Region
12.1 Global Aprepitant Market Size Forecast by Region
12.1.1 Global Aprepitant Forecast by Region (2023-2028)
12.1.2 Global Aprepitant Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aprepitant Forecast by Type
12.7 Global Aprepitant Forecast by Application
13 Key Players Analysis
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Aprepitant Product Offered
13.1.3 Merck & Co. Aprepitant Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Heron Therapeutics
13.2.1 Heron Therapeutics Company Information
13.2.2 Heron Therapeutics Aprepitant Product Offered
13.2.3 Heron Therapeutics Aprepitant Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Heron Therapeutics Main Business Overview
13.2.5 Heron Therapeutics Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Aprepitant Product Offered
13.3.3 Sandoz Aprepitant Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Information
13.4.2 Glenmark Pharmaceuticals Aprepitant Product Offered
13.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Glenmark Pharmaceuticals Main Business Overview
13.4.5 Glenmark Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Aprepitant Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Aprepitant Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Aprepitant Sales by Type (2017-2022) & (K Units)
Table 6. Global Aprepitant Sales Market Share by Type (2017-2022)
Table 7. Global Aprepitant Revenue by Type (2017-2022) & ($ million)
Table 8. Global Aprepitant Revenue Market Share by Type (2017-2022)
Table 9. Global Aprepitant Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Aprepitant Sales by Application (2017-2022) & (K Units)
Table 11. Global Aprepitant Sales Market Share by Application (2017-2022)
Table 12. Global Aprepitant Revenue by Application (2017-2022)
Table 13. Global Aprepitant Revenue Market Share by Application (2017-2022)
Table 14. Global Aprepitant Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Aprepitant Sales by Company (2020-2022) & (K Units)
Table 16. Global Aprepitant Sales Market Share by Company (2020-2022)
Table 17. Global Aprepitant Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Aprepitant Revenue Market Share by Company (2020-2022)
Table 19. Global Aprepitant Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Aprepitant Producing Area Distribution and Sales Area
Table 21. Players Aprepitant Products Offered
Table 22. Aprepitant Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Aprepitant Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Aprepitant Sales Market Share Geographic Region (2017-2022)
Table 27. Global Aprepitant Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Aprepitant Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Aprepitant Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Aprepitant Sales Market Share by Country/Region (2017-2022)
Table 31. Global Aprepitant Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Aprepitant Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Aprepitant Sales by Country (2017-2022) & (K Units)
Table 34. Americas Aprepitant Sales Market Share by Country (2017-2022)
Table 35. Americas Aprepitant Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Aprepitant Revenue Market Share by Country (2017-2022)
Table 37. Americas Aprepitant Sales by Type (2017-2022) & (K Units)
Table 38. Americas Aprepitant Sales Market Share by Type (2017-2022)
Table 39. Americas Aprepitant Sales by Application (2017-2022) & (K Units)
Table 40. Americas Aprepitant Sales Market Share by Application (2017-2022)
Table 41. APAC Aprepitant Sales by Region (2017-2022) & (K Units)
Table 42. APAC Aprepitant Sales Market Share by Region (2017-2022)
Table 43. APAC Aprepitant Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Aprepitant Revenue Market Share by Region (2017-2022)
Table 45. APAC Aprepitant Sales by Type (2017-2022) & (K Units)
Table 46. APAC Aprepitant Sales Market Share by Type (2017-2022)
Table 47. APAC Aprepitant Sales by Application (2017-2022) & (K Units)
Table 48. APAC Aprepitant Sales Market Share by Application (2017-2022)
Table 49. Europe Aprepitant Sales by Country (2017-2022) & (K Units)
Table 50. Europe Aprepitant Sales Market Share by Country (2017-2022)
Table 51. Europe Aprepitant Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Aprepitant Revenue Market Share by Country (2017-2022)
Table 53. Europe Aprepitant Sales by Type (2017-2022) & (K Units)
Table 54. Europe Aprepitant Sales Market Share by Type (2017-2022)
Table 55. Europe Aprepitant Sales by Application (2017-2022) & (K Units)
Table 56. Europe Aprepitant Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Aprepitant Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Aprepitant Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Aprepitant Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Aprepitant Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Aprepitant Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Aprepitant Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Aprepitant Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Aprepitant Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Aprepitant
Table 66. Key Market Challenges & Risks of Aprepitant
Table 67. Key Industry Trends of Aprepitant
Table 68. Aprepitant Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Aprepitant Distributors List
Table 71. Aprepitant Customer List
Table 72. Global Aprepitant Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Aprepitant Sales Market Forecast by Region
Table 74. Global Aprepitant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Aprepitant Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Aprepitant Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Aprepitant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Aprepitant Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Aprepitant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Aprepitant Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Aprepitant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Aprepitant Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Aprepitant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Aprepitant Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Aprepitant Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Aprepitant Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Aprepitant Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Aprepitant Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Aprepitant Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Aprepitant Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Aprepitant Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck & Co. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck & Co. Aprepitant Product Offered
Table 94. Merck & Co. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Merck & Co. Main Business
Table 96. Merck & Co. Latest Developments
Table 97. Heron Therapeutics Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 98. Heron Therapeutics Aprepitant Product Offered
Table 99. Heron Therapeutics Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Heron Therapeutics Main Business
Table 101. Heron Therapeutics Latest Developments
Table 102. Sandoz Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 103. Sandoz Aprepitant Product Offered
Table 104. Sandoz Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Sandoz Main Business
Table 106. Sandoz Latest Developments
Table 107. Glenmark Pharmaceuticals Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 108. Glenmark Pharmaceuticals Aprepitant Product Offered
Table 109. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Glenmark Pharmaceuticals Main Business
Table 111. Glenmark Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Aprepitant
Figure 2. Aprepitant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aprepitant Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Aprepitant Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Aprepitant Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Oral
Figure 11. Global Aprepitant Sales Market Share by Type in 2021
Figure 12. Global Aprepitant Revenue Market Share by Type (2017-2022)
Figure 13. Aprepitant Consumed in Hospital
Figure 14. Global Aprepitant Market: Hospital (2017-2022) & (K Units)
Figure 15. Aprepitant Consumed in Drug store
Figure 16. Global Aprepitant Market: Drug store (2017-2022) & (K Units)
Figure 17. Global Aprepitant Sales Market Share by Application (2017-2022)
Figure 18. Global Aprepitant Revenue Market Share by Application in 2021
Figure 19. Aprepitant Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Aprepitant Revenue Market Share by Company in 2021
Figure 21. Global Aprepitant Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Aprepitant Revenue Market Share by Geographic Region in 2021
Figure 23. Global Aprepitant Sales Market Share by Region (2017-2022)
Figure 24. Global Aprepitant Revenue Market Share by Country/Region in 2021
Figure 25. Americas Aprepitant Sales 2017-2022 (K Units)
Figure 26. Americas Aprepitant Revenue 2017-2022 ($ Millions)
Figure 27. APAC Aprepitant Sales 2017-2022 (K Units)
Figure 28. APAC Aprepitant Revenue 2017-2022 ($ Millions)
Figure 29. Europe Aprepitant Sales 2017-2022 (K Units)
Figure 30. Europe Aprepitant Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Aprepitant Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Aprepitant Revenue 2017-2022 ($ Millions)
Figure 33. Americas Aprepitant Sales Market Share by Country in 2021
Figure 34. Americas Aprepitant Revenue Market Share by Country in 2021
Figure 35. United States Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Aprepitant Sales Market Share by Region in 2021
Figure 40. APAC Aprepitant Revenue Market Share by Regions in 2021
Figure 41. China Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Aprepitant Sales Market Share by Country in 2021
Figure 48. Europe Aprepitant Revenue Market Share by Country in 2021
Figure 49. Germany Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Aprepitant Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Aprepitant Revenue Market Share by Country in 2021
Figure 56. Egypt Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Aprepitant Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Aprepitant in 2021
Figure 62. Manufacturing Process Analysis of Aprepitant
Figure 63. Industry Chain Structure of Aprepitant
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
